Dow Stock Drops Following UBS Price Target Cut
Dow shares are falling Friday after a Wall Street price target cut underscored ongoing margin pressures in global commodity chemicals sector.
Stocks · News reference
Dow Says At Morgan Stanley Conference It Completed Site Transformation At Six Sites And Started Work At Three More In Q3; Says It Will Continue Non-Core Divestitures And Asset Shutdowns Where Value Cannot Be Created
https://event.webcasts.com/starthere.jsp?ei=1774852&tp_key=3cdbee36e2&tp_special=8
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Shares of chemical and coatings companies are trading lower after Iran's Foreign Minister confirmed that Iran has submitted to the U.S. a seven-day plan to reopen the Strait of Hormuz and start discussions on Iran's nuclear program. The return of restricted Gulf-region exports to global markets may pressure margins.
UBS Maintains Neutral on Dow, Lowers Price Target to $30
UBS analyst Joshua Spector maintains Dow (NYSE:DOW) with a Neutral and lowers the price target from $32 to $30.
Germany Chemical Licensing Market Outlook Report 2026-2031 | Demand for Compliant, Sustainable Processes Creates Licensing Opportunities in Petrochemicals and Pharma, Global IP Monetization, and Research Partnerships
Germany's chemical licensing market is projected to grow from USD 1.2 billion in 2026 to USD 1.3 billion by 2031, with a CAGR of 1.6%. Growth is driven by demand for compliant, sustainable chemical technologies across petrochemicals and pharmaceuticals, supported by Germany's advanced industrial infrastructure and regulatory requirements. However, high compliance costs and technical complexity pose challenges, particularly for SMEs.